Atrial Fibrillation Trial to Evade Recurrence: effectS of Hiit Before electrO-Cardioversion for 3-weeKs (AFTERSHOCK)
Persistent Atrial Fibrillation
About this trial
This is an interventional other trial for Persistent Atrial Fibrillation
Eligibility Criteria
Inclusion Criteria:
- Persistent atrial fibrillation
- Eligible and scheduled for electro-cardioversion at UOHI
- Rate controlled with a resting ventricular rate of equal to or less than 100bpm
- Between 18-85 years of age
- Owns a Smartphone
- Physically able to participate in exercise
- Willing and able to provide written, informed consent
- Willing and able to return for follow-up visits
- Willing and able to provide daily ECG recordings using the AliveCor system for the duration of the study.
Exclusion Criteria:
- Participating in routine exercise training (more than two times per week) in the past 3 months
- Atrial Flutter secondary to ablation
- Unstable angina
- Diagnosed with severe mitral or aortic stenosis, hypertrophic obstructive cardiomyopathy
- Pregnant, lactating or planning to become pregnant during the study period
- Diagnosed with rheumatic heart disease
Sites / Locations
- University of Ottawa Heart Institute
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
High-intensity interval training (HIIT)
Usual Care Control
Participants in the HIIT group will receive 3-weeks of tri-weekly supervised exercise sessions at the University of Ottawa Heart Institute prior to their scheduled electro-cardioversion. The session will last 23 minutes in duration and consist of a 2-minute warm-up at 50% of peak power output (PPO), 2 x 8-minute interval training blocks of 30 seconds at 80-100% of PPO interspersed with 30-seconds of active recovery and a 1-minute cool down at 25 % of PPO. The sessions will be lead by a Registered Kinesiologist.
Participants assigned to the control group will have usual care, which involves no behavioural interventions leading up to their electro-cardioversion.